Clinical Trial Update: Curcumin in Treating Patients With Familial Adenomatous Polyposis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating curcumin for Familial Adenomatous Polyposis has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Familial Adenomatous Polyposis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-29